Synteract Inc. Enhances Safety Reporting Capabilities With ORACLE Adverse Event Reporting System(R) (AERS)

Jun 09, 2004, 01:00 ET from Synteract, Inc.

    SAN DIEGO, June 9 /PRNewswire/ -- Synteract, Inc. announces successful
 upgrade and full validation of Oracle AERS(R), version 4.3.  Using AERS,
 Synteract continues to perform safety surveillance, reporting and management,
 and is a value-added service provider of the product.  The upgraded version
 has enhanced medical information and product complaint features.  The
 Company's Safety Department specializes in the performance of
 pharmacovigilance services, such as case entry, safety monitoring and
 assessment, regulatory submission and reporting, and safety database
     Synteract also offers secured access to AERS as an Application Service
 Provider (ASP).  This allows clients the ability to enter, track and report
 their safety data from any location, while Synteract provides the technical
 support and maintenance of the system.
     Oracle AERS is a full-featured adverse event reporting system, designed to
 meet safety data processing needs for regulatory submission and marketing
 surveillance and reporting by pharmaceutical, biotechnology, and biomedical
 firms.  As a single repository of data, the system features custom query for
 data browsing and audit trail to track all changes to information.  Synteract
 has been using AERS (formerly known as EventNet) for three years.
     "Synteract's growing utilization and expertise with AERS allows us to
 better serve our clients, not only by helping to meet their product safety
 reporting needs, as required under law, but also by assisting with an ever
 expanding focus to proactively identify product safety issues through ongoing
 trend monitoring and analysis", stated Stewart Bieler, Vice President of
 Clinical Operations at Synteract.
     About Synteract Inc.
     Established in 1995, Synteract is a privately held, full-service contract
 research organization, dedicated to meeting the various needs of
 biotechnology, biomedical, pharmaceutical, and drug industry firms.  Based in
 Carlsbad, CA, with a branch office in Pennsylvania, the Company provides
 expertise in a wide range of therapeutic areas and maintains a wealth of
 knowledge in oncology, ophthalmology, HIV, sexual dysfunction, cardiovascular
 disease, and pain.  Since 2000, it has been a key development shop for web,
 wireless and voice data solutions that speed the completion of clinical trials
 and assist in access to clinical trials information.  This includes
 technologies such as electronic data capture (EDC), interactive voice response
 systems (IVRS), and automated safety tracking and reporting.  Synteract has
 offices in Carlsbad, CA and Philadelphia, PA.  For information please visit us
 at or call (760) 268.8200.
     CONTACT: Stewart Bieler, +1-760-268-8200

SOURCE Synteract, Inc.